Last updated on November 2019

Outpatient research study of an investigational vaccine for Respiratory Syncytial Virus (RSV) for adults ages 65 and older. RSV is a common virus that can be especially dangerous in older adults and those with chronic heart or lung disease and those with weakened immune systems.


Brief description of study

RSV is a common virus that can be especially dangerous in older adults and those with chronic heart or lung disease and those with weakened immune systems.

 

Clinical Study Identifier: TX228532

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.